HealthcareServices

Transcriptomics Market Forecast 2026–2035: How to Leverage Market Growth

March 3, 2026March 3, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the transcriptomics market from 2026–2035 with trusted insights from The Business Research Company

What growth pattern is forecast for the Transcriptomics Market size between 2026 and 2035?

The transcriptomics market size has demonstrated significant expansion in recent years. It is anticipated to increase from $7.04 billion in 2025 to $7.61 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.1%. The upward trend observed historically can be ascribed to breakthroughs in sequencing technologies, a reduction in the expense of high-throughput analysis, the broadening scope of academic genomics research, the establishment of standardized transcriptomic workflows, and an increment in life sciences funding.

The transcriptomics market is anticipated to experience robust growth in the coming years, with its size expected to reach $10.3 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 7.8%. This growth during the forecast period is attributed to several factors, including the increasing integration of AI-driven data analysis, a rising demand for personalized therapeutics, the expansion of clinical transcriptomics applications, growing investments in omics research infrastructure, and the increasing pharmaceutical adoption of transcriptomic profiling. Key trends for the forecast period include the increasing adoption of RNA sequencing technologies, the growing use of single-cell transcriptomics, the expansion of bioinformatics and data analytics platforms, a rising demand for biomarker discovery applications, and an enhanced focus on precision medicine.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24417&type=smp

Which Drivers Are Impacting Market Performance In The Transcriptomics Market?

The expanding integration of personalized medicine is projected to stimulate the growth of the transcriptomics market in the future. Personalized medicine defines a medical methodology that tailors treatment based on an individual’s genetic makeup, lifestyle, and environmental factors. Its expansion is fueled by advancements in genetic sequencing, which allows for treatments customized to individual genetic profiles for superior efficacy. Transcriptomics identifies unique gene expression profiles, thereby guiding personalized treatments according to a patient’s specific biology. This enhances therapeutic effectiveness, minimizes undesirable effects, and facilitates early disease diagnosis. For example, in February 2024, the Personalized Medicine Coalition, a US-based hospital and health care organization, stated that the FDA granted approval to 16 new personalized treatments for rare disease patients in 2023, a rise from six approvals in 2022. Consequently, the increasing embrace of personalized medicine is a primary force behind the growth of the transcriptomics market.

What Segment Types Are Examined In The Transcriptomics Market?

The transcriptomics market covered in this report is segmented –

1) By Type: Instruments, Consumables, Software, Services

2) By Technology: Micro Array, Real-Time Quantitative Polymerase Chain Reaction, Sequencing Technologies

3) By Application: Diagnostics And Disease Profiling, Drug Discovery, Other Applications

4) By End-User: Academic And Research Institutes, Pharmaceutical Companies, Biotechnology Companies, Other End-Users

Subsegments:

1) By Instruments: Microarray Instruments, Sequencing Instruments, Polymerase Chain Reaction (PCR) Instruments, Other Transcriptomics Instruments

2) By Consumables: Reagents, Probes, Kits, Chips

3) By Software: Data Analysis Software: Data Management Software, Visualization Software: Bioinformatics Software

4) By Services: Data Analysis Services, Sample Preparation Services, Sequencing Services, Consulting Services

Which Trends Are Influencing The Performance And Direction Of The Transcriptomics Market?

Leading companies in the transcriptomics market are concentrating on the development of sophisticated products, such as single-cell spatial panels, to generate more profound insights into cellular functions and disease mechanisms. These single-cell spatial panels evaluate gene expression at an individual cell level, while preserving the spatial location of each cell within its tissue context. They integrate single-cell transcriptomics with spatial data, thereby offering understanding into both cellular activity and tissue architecture. For example, in February 2024, NanoString Technologies, a US-based biotechnology company, unveiled the CosMx 6,000 plex RNA Assay, a spatial molecular imaging assay. This launch represents the commercial introduction of the industry’s premier single-cell spatial panel, capable of measuring more than 6,000 RNA targets across almost all human biological pathways. This significant advancement, designed for compatibility with the CosMx Spatial Molecular Imager (SMI), allows researchers to perform gene profiling with single-cell and subcellular resolution, exhibiting high accuracy and advanced cell segmentation.

Who Are The Prominent Global Companies Shaping The Transcriptomics Market Landscape?

Major companies operating in the transcriptomics market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Becton Dickinson and Company, Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Takara Bio Inc., 10x Genomics Inc., Oxford Nanopore Technologies plc, Genewiz Inc., Pacific Biosciences of California Inc., NanoString Technologies Inc., Singleron Biotechnologies, SCIEX, CD Genomics Inc., Parse Biosciences Inc., Lexogen GmbH, LC Sciences LLC, Arraystar Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/transcriptomics-global-market-report

Which Region Currently Holds The Largest Share Of The Transcriptomics Market?

North America was the largest region in the transcriptomics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the transcriptomics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Transcriptomics Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=24417&type=smp

Browse Through More Reports Similar to the Global Transcriptomics Market 2026, By The Business Research Company

Rna Sequencing Services Market Report 2026

https://www.thebusinessresearchcompany.com/report/rna-sequencing-services-global-market-report

Genomics Market Report 2026

https://www.thebusinessresearchcompany.com/report/genomics-global-market-report

Pharmacogenomics Market Report 2026

https://www.thebusinessresearchcompany.com/report/pharmacogenomics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795